Background: Chronic pain has a substantial negative impact on work-related outcomes, which underscores the importance of interventions to reduce the burden. Spinal cord stimulation (SCS) efficiently causes pain relief in specific chronic pain syndromes. The aim of this review was to identify and summarize evidence on returning to work in patients with chronic pain treated with SCS.
MATERIALS AND METHODS

Search Strategy and Selection Criteria
This systematic review and meta-analysis were conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) guidance (12) . The electronic databases of PubMed, EMBASE, SCOPUS, and Web of Science were searched from inception to October 20, 2017 to identify potentially relevant studies.
The search strategy was based on the PICO (evidence based search strategy focusing on patient/population, intervention, comparison and outcome) framework (13) (Appendix A and Appendix B). Our search was not limited to randomized controlled trials (RCTs) but also included case series. A language restriction of English, French, German, and Dutch was applied. We included studies that met the following criteria: (1) population-adult (≥18 years old) chronic pain patients eligible for SCS; (2) intervention-SCS; (3) outcome-RTW, employment status and sick leave. We excluded studies enrolling patients receiving other types of neuromodulation and publications available only in abstract form or meeting reports.
Data Extraction and Quality Assessment
After combining search results from different databases and removing duplicates by using EndNote reference manager, two investigators (MM and LG) independently reviewed all the retrieved abstracts and full texts to remove ineligible studies. In case of disagreement, consensus was sought through consultation and discussion with a third party (RB). The two reviewers (MM and LG) independently extracted data from included studies, using an a priori determined data extraction form comprising the following items: (1) first author; (2) year of publication; (3) country; (4) sample size in relation to RTW outcome; (5) study design; (6) diagnosed population; (7) type of SCS; (8) all predefined outcomes. The quality of the included studies was evaluated using the risk of bias Downs and Black checklist (modified version) (14) (Appendix C). We assigned a value of 0 or 1 to the different subcategories of the following items: reporting, external validity, and internal validity. A total score < 10/16 was considered to be low quality, while scores ≥ 10/16 were presumed to be high quality. Discrepancies were identified and resolved through discussion.
Outcome and Statistical Analysis
The primary goal of this study was to identify the prevalence of work resumption after implantation of SCS. Subgroup analyses were performed to evaluate the occupational status at last follow-up point. The results from all relevant studies were merged to estimate the pooled odds ratio (OR) and associated 95% confidence intervals (CIs) for dichotomous outcomes. The outcomes were pooled using a random effects model. All p < 0.05 were considered statistically significant. Heterogeneity was tested with I 2 statistics. This statistic can be interpreted as the proportion of the total variation in the estimated treatment effect due to the heterogeneity among studies (15) . To explore the robustness and the potential influence of various factors on our primary outcome, we performed a subgroup analysis based on pathology (back and leg pain versus mixed). The Dixon's Q test for the rejection of extreme values (at the 5 and 1% levels) was performed to identify outliers (16) . Publication bias was evaluated by visual inspection of the funnel plot. All statistical analyses were performed using RStudio (version 0.99.903, RStudio, Inc.).
RESULTS
Study Selection
A flowchart of the search strategy and the reasons for exclusion are shown in Figure 1 . The initial search identified a total of 2835 citations. After combining the results, removing duplicates and selections based on the title and abstract, 54 full-text studies remained. Thirty-nine studies were excluded after reviewing the full text: 10 because of inappropriate outcome parameters (no RTW mentioned), 28 because of unsuitable study design or conference meeting abstract and, 1 because no full text was available even after communication with the first author. Thus, 15 fulltext studies were read for further evaluation. Of those 15 studies, 6 were excluded because they did not provide sufficient information on the occupational status at last follow-up point (17) (18) (19) (20) (21) (22) , 1 was excluded because the studied population was reported in another study (23, 24) , and 1 study did not pass the outlier test (25) . This study from Harke et al. was considered an outlier at the level 5 and at the 1% (25) . Finally, the remaining seven, which enrolled 824 patients, were included in the meta-analysis (23, (26) (27) (28) (29) (30) (31) .
Study Characteristics and Quality
The main characteristics and predefined outcome data of the included studies for the systematic review are described in Table 1 . These studies were published between 1978 and 2017, with sample sizes ranging from 20 to 410. One RCT was included, five retrospective case series and one prospective cohort study. One study evaluated high-frequency SCS, while the other studies reported on the use of conventional SCS (29) . The mean follow-up period varied from 1 to 7.1 years. Three studies were included with a study population suffering from back and/or leg pain (FBSS with axial back pain and unilateral limb pain), while four other studies described a more heterogeneous study population (i.e., FBSS, multiple sclerosis, spinal cord injury, vascular disease, cancer, occipital neuralgia, trauma, and peripheral neuropathy). The risk of bias Downs and Black checklist score for each citation varied across the studies, ranging from 10 to 16 out of 17.
Primary Outcome Occupational Status
The number of patients working after SCS was mentioned in all seven studies. The pooled analysis showed that SCS increases the odds to work after SCS (7 studies; N = 824, OR 2.15; 95% CI, 1.44-3.21; I 2 = 42%; p = 0.0001). Given the moderate heterogeneity, a subgroup based on the type of population also was evaluated. The type of population (chronic back and/or leg pain versus mixed pain syndromes) was defined to be a factor influencing heterogeneity (Fig. 2) .
In general, both subgroups analyses confirmed similar OR of working status among groups.
The funnel plot shows no publication bias (Appendix D).
Return to Work %RTW, defined as the percentage of patients going back to work who were unemployed before treatment, was reported or could be calculated in all seven studies. The %RTW varied between 10 and 47 (mean 14). The pooled analysis showed that SCS increases the odds to RTW after SCS in patients with absenteeism before treatment (7 studies; N = 701, OR 29.06; 95% CI, 9.73-86.75; I 2 = 0%; p < 0.0001). The funnel plot shows no publication bias (Appendix E).
Secondary Outcomes
The types of employment after returning to work were not reported in all seven studies. Three studies described the number of patients with part-time and full-time employment after SCS implantation at the last follow-up (29, 30, 32) . Two studies also mentioned the numbers of patients who increased working time after SCS implantation (26, 30) . One study presented the percentage of patients with SCS working at various follow-up points (31) . Yet another study reported the median time of unemployment (28) .
DISCUSSION
In the past two decades, SCS for pain relief has evolved to include many new methods of current delivery by neurostimulation devices (3). This resulted in several studies presenting excellent results on pain reduction. Although the status of "remission," or achieving almost complete pain relief by SCS, for some patients has been reported, occupational outcomes, such as RTW, are rarely an outcome parameter in neuromodulation studies (33) . SCS has shown superior efficacy to conventional medical management in an FBSS population and SCS leads to long-term health care cost savings (28, 34) . These data support the long-term cost utility of SCS in the treatment of FBSS patients (34) . However, in a chronic pain population, it is wellknown that two thirds of the total health care costs are represented by indirect costs (loss of productivity or working days lost) (35). Working at baseline: number of patients at work at baseline. Working after SCS: number of patients at work after SCS at the latest follow-up point.
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Our epidemiologic meta-analysis included seven studies with 824 patients investigated occupational outcomes. Despite the clinical heterogeneity of the subgroup "chronic back and leg pain," the results for this subgroup appeared to be statistically homogenous and this in contrast to the subgroup with mixed diagnoses. This can be explained by the fact that the mixed group consists of various diagnoses with variable evidence for SCS, while SCS for chronic low back pain has proven to be effective and has reached a recommendation in the recent European Academy of Neurology guidelines (36) .
This meta-analysis showed that, among chronic pain patients, SCS improves the odds of returning to work and that SCS results in more patients at work, compared with the same population before SCS.
In terms of %RTW, the percentage of patients going back to work who were unemployed before treatment, SCS seems to allow chronic pain patients to work again. Since SCS candidates are refractory to conventional pain therapy and therefore difficult to treat, a mean of 14% of unemployed patients returning to work should be born in mind. However, no information is available in these studies on the type of work the patients are returning to. Although three studies reported the number of patients returning to work on a part-time basis, the relevant number of hours worked daily was not mentioned (24, 26, 30) . Young et al. considered returning to household duties or to studying as returning to gainful employment (31) . It is generally accepted that patients at working age or defined as patients under the age of 65 are more likely to RTW. This specific subdivision of patients receiving SCS was reported only in a minority of the reviewed studies (28) (29) (30) .
The number of patients found in this meta-analysis is similar to the findings of the systematic review of Frey et al. in 2009 (37) . They summarized a 13% entry in gainful employment and RTW in 16-31% of FBSS patients (37) .
Researchers agree that both job loss and continuing "worklessness" impact adversely on people's health with increased levels of both mental and physical problems (38) .
Notwithstanding the evidence of using classical pain relief, functionality, and quality of life as outcome measurements in chronic pain studies, RTW as a central determinant of (mental) health, also should be considered as an important clinical outcome measure.
Additionally, Elfering et al. reported that only measuring global work status and %RTW as work-related outcome parameters, lack specificity (39). In-depth and detailed analyses, clear definitions, disjunctive classes of categories and adequate time frames might upgrade this specificity. Job description and educational level, type of employment (full-time, part-time, or casual), reasons for unemployment, work-related attitudes (e.g., job satisfaction, workrelated expectations, …) and other risk factors for chronic disability also may be taken in consideration (39, 40) .
STRENGTHS AND LIMITATIONS
To diminish bias, the study selection, data extraction, and evaluation of study quality were performed by two independent reviewers. We comprehensively analyzed the odds of working and the odds of RTW after SCS treatment in studies with different designs.
There also were several potential limitations regarding our meta-analysis. First, some well-designed studies were excluded because they lacked essential information about the work status of all patients. Second, the sample size was small as only seven studies were included. Third, the bias of the publications might have affected the validity of our conclusions, such as lack of comparison (e.g., best medical treatment, other types of therapies, …). And finally, the search method was limited to MEDLINE, EMBASE, Web of Science, and SCOPUS. We did not search the "gray literature" (trial registries nor backward references).
CONCLUSIONS
In summary, based on available data, this meta-analysis demonstrates that SCS treatment results in more patients at work and also more patients returning to work. More, large-scale studies are warranted to analyze in detail the work status of the included patients (type of job, full-time, part-time, % patients at working age, etc.). on an excellent meta-analysis of return to work outcome in spinal cord stimulation (SCS) patients. Their statistical analysis is well done and provides strong support that SCS has a high likelihood of returning patients to work. Future studies of SCS should include data on this important outcome and return to work statistics will assuredly strengthen the cost-effectiveness of this neuromodulation modality. This paper is a valuable contribution to the literature.
